[Chinese Academy of Atomic Energy Research Li Fenglin: the market size of radiopharmaceuticals in China is expected to exceed 10 billion in 2025] on May 25, Li Fenglin, a researcher at the Comprehensive Institute of Nuclear Technology Application Research Institute of China Atomic Energy Research Institute, said at the 2023 International Conference on the Application of Nuclear Technology Industry that eight medical isotopes, including 99Mo, 125i and 131I, are commonly used in the field of nuclear medicine. It is conservatively estimated that annual demand will grow at a rate of 5 per cent, with an average annual growth rate of 25 per cent, and total demand is expected to increase more than tenfold by 2030. According to Li Fenglin, it is estimated that by 2030, the global radiopharmaceuticals market will reach 11.93 billion US dollars. The market scale of radiopharmaceuticals in China is expected to exceed 12.7 billion yuan in 2025.